Compare Alibaba Group (BABA) vs Inovio Pharmaceuticals Inc (INO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Alibaba Group vs Inovio Pharmaceuticals Inc — how do they compare? Alibaba Group trades at $125.7 (market cap $308.93B), while Inovio Pharmaceuticals Inc trades at $0.8 (market cap $78.55M). The key difference: Alibaba Group is far larger — about 3932.9× Inovio Pharmaceuticals Inc's market cap, and Alibaba Group pays a 0.82% dividend while Inovio Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| BABA | INO | |
|---|---|---|
Market Cap | $308.93B | $78.55M |
Volume | 18,069,938 | — |
Sector | Consumer Cyclical | Health |
52-Week High | $189.34 | $2.87 |
52-Week Low | $94.83 | $0.66 |
Enterprise Value | $303.72B | $49.56M |
Dividend Yield | 0.82% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Alibaba Group
Alibaba Group Holding Limited operates as a holding company. The Company provides internet infrastructure, electronic commerce, online financial, and internet content services through its subsidiaries. Alibaba Group Holding offers its products and services worldwide.
Read more on BABA →About Inovio Pharmaceuticals Inc
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →
